Goldman Sachs Group »

Cara Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $156k 210k 0.74
2023-09-30 $227k 135k 1.68
2023-06-30 $809k 286k 2.83
2023-03-31 $1.5M 304k 4.91
2022-12-31 $3.2M 296k 10.74
2022-06-30 $1.3M 145k 9.12
2022-03-31 $1.6M 128k 12.15
2021-12-31 $1.5M 126k 12.17
2021-09-30 $4.7M 307k 15.45
2021-03-31 $9.6M 443k 21.71
2020-12-31 $9.1M 601k 15.13
2020-09-30 $7.8M 616k 12.72
2020-06-30 $5.5M 323k 17.10
2019-12-31 $4.1M 253k 16.11
2019-09-30 $5.5M 301k 18.28
2019-06-30 $1.9M 90k 21.50
2019-03-31 $1.1M 57k 19.61
2018-12-31 $1.2M 95k 13.00
2018-09-30 $3.8M 160k 23.95
2018-06-30 $4.1M 212k 19.15
2018-03-31 $372k 30k 12.36
2017-12-31 $965k 79k 12.24
2017-09-30 $1.1M 78k 13.70
2017-06-30 $3.3M 217k 15.40
2017-03-31 $216k 12k 18.35
2016-12-31 $282k 30k 9.29
2016-09-30 $231k 28k 8.34
2016-06-30 $135k 28k 4.79
2016-03-31 $79k 13k 6.24